Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
By Julie Steenhuysen and Michael Erman CHICAGO (Reuters) – Merck & Co Inc <MRK.N>,...
Read More
Updated
Germany extends social distancing rules until June 29
By Andreas Rinke and Michael Nienaber BERLIN (Reuters) – Germany’s government and its...
Read More
Britain to provide anti-viral drug remdesivir to some COVID-19 patients
LONDON (Reuters) – Britain will provide the anti-viral drug remdesivir to certain COVID-19...
Read More
WHO says the Americas are new COVID-19 epicenter as deaths surge in Latin America
By Anthony Boadle BRASILIA (Reuters) – The Americas have emerged as the new epicenter of the...
Read More
Brazil coronavirus deaths could surpass 125,000 by August, U.S. study says
BRASILIA (Reuters) – As Brazil’s daily COVID-19 death rate climbs to the highest in...
Read MoreNovavax launches its first coronavirus vaccine test on humans
(Reuters) – U.S. biotech company Novavax Inc has joined the race to test coronavirus vaccine candidates on humans and said it was targeting production of over a billion doses of its vaccine candidate next year. The...
Read More
Data puzzle as Spain tweaks coronavirus tracking system
MADRID (Reuters) – Spain’s Health Ministry on Tuesday defended changes to its...
Read More
UK COVID-19 death toll tops 47,000 as pressure heaps on PM Johnson
By Andy Bruce LONDON (Reuters) – The United Kingdom’s COVID-19 death toll surpassed...
Read More
France again ranks No. 4 in COVID-19 deaths as Spain revises tally
By Geert De Clercq PARIS (Reuters) – France again ranked fourth in coronavirus deaths after...
Read MoreLilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in second quarter
(Reuters) – Shanghai Junshi Biosciences Co Ltd said on Tuesday it plans to start clinical studies to test its experimental antibody against COVID-19 in the United States and China in the second quarter of the year, with...
Read More
Exclusive: Indonesia, major advocate of hydroxychloroquine, told by WHO to stop using it
By Kate Lamb and Tom Allard (Reuters) – The World Health Organization has urged Indonesia,...
Read More
Japanese face ‘new normal’ after coronavirus emergency lifted
By Akiko Okamoto and Chang-Ran Kim TOKYO (Reuters) – A day after Japan ended its state of...
Read More
India has low coronavirus death rate but worries about migrants on the move
By Rupam Jain MUMBAI (Reuters) – India on Tuesday recorded a total of 145,380 coronavirus...
Read MoreHealthineers ready to boost antibody test production to 50 million per month
By Ludwig Burger and Alexander Hübner FRANKFURT (Reuters) – Siemens Healthineers stands ready to ramp up production of its antibody test to more than 50 million per month from June as governments across the world are keen...
Read More
Covid-19 tests within 24 hours for symptomatic Bavarians: state premier
MUNICH (Reuters) – Bavaria, one of the German states hardest hit by the coronavirus...
Read MoreIndia’s Glenmark to study potential COVID-19 drug combination
BENGALURU (Reuters) – Glenmark Pharmaceuticals Ltd <GLEN.NS> said on Tuesday it would begin a clinical trial in India to test a combination of two anti-viral drugs, favipiravir and umifenovir, as a potential COVID-19...
Read More
Global fundraising for COVID-19 vaccine, drugs exceeds $10 billion, EU says
BRUSSELS (Reuters) – A global campaign to fund the development of vaccines and therapies...
Read More
Thailand extends virus emergency powers amid opposition suspicion
BANGKOK (Reuters) – Thailand’s cabinet on Tuesday extended an emergency decree to...
Read MoreMalaysia reports 187 new coronavirus cases, no new deaths
KUALA LUMPUR (Reuters) – Malaysia reported 187 new coronavirus cases on Tuesday, with illegal migrants held at a detention centre accounting for most of them, bringing the total number of infections in the country to...
Read More
After coronavirus, Italian nursing homes face fight to survive
By Emilio Parodi MILAN (Reuters) – Italy’s nursing homes, ravaged by the coronavirus...
Read More